PHARMACIE MEIGNIE : revenue, balance sheet and financial ratios

PHARMACIE MEIGNIE is a French company founded 18 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LESPARRE-MEDOC (33340), this company of category PME shows in 2022 a revenue of 3.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE MEIGNIE (SIREN 502860836)
Indicator 2025 2023 2022 2021 2020 2018 2017 2016
Revenue N/C N/C 3 109 397 € N/C 2 108 902 € 1 612 510 € 1 694 630 € 1 751 552 €
Net income 250 610 € 72 636 € 292 349 € 101 680 € 70 761 € 70 636 € 53 397 € 74 210 €
EBITDA N/C N/C 413 495 € N/C 112 482 € 94 817 € 94 503 € 135 836 €
Net margin N/C N/C 9.4% N/C 3.4% 4.4% 3.2% 4.2%

Revenue and income statement

En 2025, PHARMACIE MEIGNIE genera un resultado neto positivo de 251 k€. Evolución 2016-2025: 74 k€ -> 251 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

250 610 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 28%. Este nivel muy bajo refleja una estructura financiera sólida. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 63%. Esta alta autonomía significa que la empresa financia la mayoría de sus activos con fondos propios.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

27.979%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

63.181%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

48.1%

Solvency indicators evolution
PHARMACIE MEIGNIE

Sector positioning

Ratio de endeudamiento
27.98 2025
2022
2023
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Bueno -22 pts over 3 years

En 2025, el ratio de endeudamiento de PHARMACIE MEIGNIE (27.98) se sitúa por debajo de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Esta posición controlada refleja una gestión prudente.

Autonomía financiera
63.18% 2025
2022
2023
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Bueno +23 pts over 3 years

En 2025, el autonomía financiera de PHARMACIE MEIGNIE (63.2%) se sitúa por encima de la mediana del sector. Este ratio representa la parte del patrimonio en la financiación total. Esta posición cómoda ofrece un margen de seguridad apreciable.

Capacidad de reembolso
3.1 ans 2022
2022
Q1: 1.29 ans
Med: 3.55 ans
Q3: 6.63 ans
Bueno

En 2022, el capacidad de reembolso de PHARMACIE MEIGNIE (3.1 ans) se sitúa por debajo de la mediana del sector. Este ratio indica el número de años necesarios para pagar la deuda con flujo de caja. Esta posición controlada refleja una gestión prudente.

Liquidity ratios

El ratio de liquidez se sitúa en 107.70. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

107.701

Liquidity indicators evolution
PHARMACIE MEIGNIE

Sector positioning

Ratio de liquidez
107.7 2025
2022
2023
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Vigilar

En 2025, el ratio de liquidez de PHARMACIE MEIGNIE (107.70) se sitúa en el 25% más bajo del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Un ratio inferior a 1 puede señalar tensiones potenciales de flujo de caja.

Cobertura de intereses
1.51x 2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average

En 2022, el cobertura de intereses de PHARMACIE MEIGNIE (1.5x) se sitúa por debajo de la mediana del sector. Este ratio indica cuántas veces el resultado operativo cubre los gastos de intereses. Una mejora fortalecería la posición competitiva.

Working capital requirement (WCR) and payment terms

El fondo de maniobra operativo (FM) mide el desfase temporal de tesorería.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE MEIGNIE

Positioning of PHARMACIE MEIGNIE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE MEIGNIE is estimated at 3 980 969 € (range 2 701 504€ - 6 246 689€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
2701k€ 3980k€ 6246k€
3 980 969 € Range: 2 701 504€ - 6 246 689€
NAF 5 année 2025

Valuation method used

Net Income Multiple
250 610 € × 15.9x = 3 980 970 €
Range: 2 701 505€ - 6 246 690€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE MEIGNIE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE MEIGNIE

What is the revenue of PHARMACIE MEIGNIE ?

The revenue of PHARMACIE MEIGNIE in 2022 is 3.1 M€.

Is PHARMACIE MEIGNIE profitable?

Yes, PHARMACIE MEIGNIE generated a net profit of 251 k€ in 2025.

Where is the headquarters of PHARMACIE MEIGNIE ?

The headquarters of PHARMACIE MEIGNIE is located in LESPARRE-MEDOC (33340), in the department Gironde.

Where to find the tax return of PHARMACIE MEIGNIE ?

The tax return of PHARMACIE MEIGNIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE MEIGNIE operate?

PHARMACIE MEIGNIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.